IL‐17 mediates estrogen‐deficient osteoporosis in an Act1‐dependent manner
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Estrogen‐deficient osteoporosis may be an inflammatory disorder and we therefore asked if IL‐17 participates in its pathogenesis. Deletion of the principal IL‐17 receptor (IL‐17RA) protects mice from ovariectomy (OVX)‐induced bone loss. Further supporting a central role of IL‐17 in its pathogenesis, OVX‐induced osteoporosis is prevented by a blocking antibody targeting the cytokine. IL‐17 promotes osteoclastogenesis by stimulating RANK ligand (RANKL) expression by osteoblastic cells, mediated by the IL‐17RA SEFIR/TILL domain. Estrogen deprivation, however does not enhance IL‐17RA mRNA expression by osteoblasts or in bone, but augments that of Act1, an IL‐17RA‐interacting protein and signaling mediator. Similar to IL‐17RA−/− mice, those lacking Act1 are protected from OVX‐induced bone loss. Also mirroring IL‐17RA‐deficiency, absence of Act1 in osteoblasts, but not osteoclasts, impairs osteoclastogenesis via dampened RANKL expression. Transduction of WT Act1 into Act1−/− osteoblasts substantially rescues their osteoclastogenic capacity. The same construct, however, lacking its E3 ligase U‐box or its SEFIR domain, which interacts with its counterpart in IL‐17RA, fails to do so. Estrogen deprivation, therefore, promotes RANKL expression and bone resorption in association with upregualtion of the IL‐17 effector, Act1, supporting the concept that post‐menopausal osteoporosis is a disorder of innate immunity. J. Cell. Biochem. 113: 2895–2902, 2012. © 2012 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00126-4 · Cited by 1,872
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440 · cited 2×
“Additionally, TNF and IL-1 synergize with the osteoclastogenic cytokine to directly stimulate precursor differentiation into the mature resorptive polykaryon [Lam et al., 2000; Wei et al., 2005].”
BackgroundSelf-citationEstrogen deficiency induces bone loss by enhancing T-cell production of TNF-α
Cenci, S., Weitzmann, M. N., Roggia, C., Namba, N., Novack, D., Woodring, J., & Pacifici, R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11066 · Cited by 705 · cited 3×
“While controversial [Lee et al., 2006], some investigators report immune-compromised mice and those lacking TNF or its receptor are protected from ovariectomy (OVX)-induced osteoporosis [Cenci et al., 2000; Roggia et al., 2001].”
BackgroundQian, Y., Liu, C., Hartupee, J., Altuntas, C. Z., Gulen, M. F., Jane-wit, D., Xiao, J., Lu, Y., Giltiay, N., Liu, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1439 · Cited by 614 · cited 3×
“Act1 is an adaptor protein required for IL-17’s induction of inflammatory cytokine expression [Qian et al., 2007].”
BackgroundSelf-citationRoggia, C., Gao, Y., Cenci, S., Weitzmann, M. N., Toraldo, G., Isaia, G., & Pacifici, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251534698 · Cited by 513 · cited 3×
“While controversial [Lee et al., 2006], some investigators report immune-compromised mice and those lacking TNF or its receptor are protected from ovariectomy (OVX)-induced osteoporosis [Cenci et al., 2000; Roggia et al., 2001].”
BackgroundAutophagy Proteins Regulate the Secretory Component of Osteoclastic Bone Resorption
DeSelm, C. J., Miller, B. C., Zou, W., Beatty, W. L., van Meel, E., Takahata, Y., Klumperman, J., Tooze, S. A., Teitelbaum, S. L., & Virgin, H. W. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.08.016 · Cited by 487 · cited 1×
“Retroviral transduction was performed as previously described [DeSelm et al., 2011].”
MethodSelf-citationAmmann, P., Rizzoli, R., Bonjour, J. P., Bourrin, S., Meyer, J. M., Vassalli, P., & Garcia, I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119333 · Cited by 310
The STIR-domain superfamily in signal transduction, development and immunity
Novatchkova, M., Leibbrandt, A., Werzowa, J., Neubüser, A., & Eisenhaber, F. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00067-7 · Cited by 255
Cited by
Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics
Li, J.-Y., Chassaing, B., Tyagi, A. M., Vaccaro, C., Luo, T., Adams, J., Darby, T. M., Weitzmann, M. N., Mulle, J. G., Gewirtz, A. T., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86062 · Cited by 643
“The importance of IL-17 in bone loss is highlighted by the fact that silencing of IL-17R (72) or treatment with an anti–IL-17 antibody (73) prevent ovx-induced bone loss.”
Osteoimmunology: The conceptual framework unifying the immune and skeletal systems
Okamoto, K., Nakashima, T., Shinohara, M., Negishi-Koga, T., Komatsu, N., Terashima, A., Sawa, S., Nitta, T., & Takayanagi, H. (2017) · Physiological Reviews · doi:10.1152/physrev.00036.2016 · Cited by 534
Tyagi, A. M., Srivastava, K., Mansoori, M. N., Trivedi, R., Chattopadhyay, N., & Singh, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044552 · Cited by 326
The role of cytokines in inflammatory bone loss
Souza, P. P. C., & Lerner, U. H. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.822766 · Cited by 269
Modulation of bone remodeling by the gut microbiota: A new therapy for osteoporosis
Lyu, Z., Hu, Y., Guo, Y., & Liu, D. (2023) · Bone Research · doi:10.1038/s41413-023-00264-x · Cited by 207
“Deficiency of IL-17RA or Act1, an IL-17RA-interacting protein, protects mice from OVX-induced bone loss.(65)”
BackgroundLi, L., Rao, S., Cheng, Y., Zhuo, X., Deng, C., Xu, N., Zhang, H., & Yang, L. (2019) · MicrobiologyOpen · doi:10.1002/mbo3.810 · Cited by 109
“In women, the increase of serum IL‐17 is closely related to osteoporosis (Molnar, Bohaty, & Somogyine‐Vari, 2014; Molnár, Bohaty, & Somogyiné‐Vári, 2014; Zhang et al., 2014).”
BackgroundInfluentialCline-Smith, A., Axelbaum, A., Shashkova, E., Chakraborty, M., Sanford, J., Panesar, P., Peterson, M., Cox, L., Baldan, A., Veis, D., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3966 · Cited by 108
“Neutralization of IL-17A((102)) and TNFα((103)) have been shown to decrease osteoporosis in response to OVX in mice.”
BackgroundFrom osteoimmunology to osteomicrobiology: How the microbiota and the immune system regulate bone
Hsu, E., & Pacifici, R. (2018) · Calcified Tissue International · doi:10.1007/s00223-017-0321-0 · Cited by 106
Bone Remodeling and the Microbiome
Pacifici, R. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031203 · Cited by 101
“The importance of IL-17 in bone loss is highlighted by the fact that silencing of IL-17R (DeSelm et al. 2012) or treatment with anti-IL-17 antibody (Tyagi et al.”
BackgroundUpregulated Cellular Expression of IL-17 by CD4+ T-Cells in Osteoporotic Postmenopausal Women
Zhao, R., Wang, X., & Feng, F. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000443531 · Cited by 51
Callus γδ T cells and microbe-induced intestinal Th17 cells improve fracture healing in mice
Dar, H. Y., Perrien, D. S., Pal, S., Stoica, A., Uppuganti, S., Nyman, J. S., Jones, R. M., Weitzmann, M. N., & Pacifici, R. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166577 · Cited by 48
Metadata
- Authors
- DeSelm, C. J., Takahata, Y., Warren, J., Chappel, J. C., Khan, T., Li, X., Liu, C., Choi, Y., Kim, Y. F., Zou, W., & Teitelbaum, S. L.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2012-07-11
- Volume
- 113
- Issue
- 9
- Pages
- 2895-2902
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2113172514
- Cited by
- 125
- References
- 15
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.